摘要
目的采用AGREEⅡ评价工具对我国眼科临床实践指南进行质量评价。方法计算机检索CBM、CNKI、VIP和WanFang Data数据库,搜集中国眼科临床实践指南,检索时限均为建库至2017年12月。3名研究者利用AGREEⅡ指南评价工具对纳入指南的质量进行评价。结果共纳入60部中国眼科临床指南。AGREEⅡ评价结果显示,在范围和目的、参与人员、制订的严谨性、表达的清晰性、应用性和编辑的独立性这6个领域的平均得分分别为66.4%、24.7%、13.5%、67.4%、14.5%和19.3%。较之前发表的指南,2013年至2017年发表指南在除表达的清晰性外的所有领域得分都有提高。结论我国现有眼科临床实践指南总体质量不高,与国际平均水平还存在较大差距。今后在指南制订过程中应更加重视遵循指南制订规范,加强参与人员多样性、制订的严谨性、指南的应用性和编辑独立性。
Objectives To evaluate the quality of ophthalmic clinical practice guidelines in China by using the AGREE Ⅱ instrument. Methods CBM, CNKI, VIP, and WanFang Data databases were electronically searched to collect Chinese guidelines for ophthalmology from inception to December 2017. Three reviewers independently evaluated theincluded guidelines using the AGREE Ⅱ instrument. Results A total of 60 Chinese clinical guidelines for ophthalmology were included. The average scores of the six domains including scope and purpose, stakeholderinvolvement, rigorism of development, clarity of presentation, applicability and editorial independence were 66.4%, 24.6%,13.5%, 67.4%, 14.5%, and 19.3%, respectively. The guidelines published from 2013 to 2017 scored higher than thosepublished previously in all areas except for domain 4 clarity of presentation. Conclusions The quality of current ophthalmic clinical practice guidelines in China is low, and there is still a big gap between them and the international guidelines. Guidelines developers should place more emphasis on developing regulations to improve stakeholder involvement, rigorism of development, applicability and editorial independence.
作者
周韦禾
郑元瑾
楼姹
郑景伟
叶聪
梁远波
ZHOU Weihe;ZHENG Yuanjin;LOU Cha;ZHENG Jingwei;YE Cong;LIANG Yuanbo(Center for Clinical and Epidemiological Studies,Eye Hospital,Wenzhou Medical University,Wenzhou,325027,P.R.China)
出处
《中国循证医学杂志》
CSCD
北大核心
2019年第1期73-83,共11页
Chinese Journal of Evidence-based Medicine
基金
浙江省卫生高层次人才计划项目(编号:2016025)
关键词
中国
眼科
临床实践指南
质量评价
AGREEⅡ
China
Ophthalmology
Clinical practice guideline
Quality assessment
AGREE Ⅱ
